PLJJF yields 4.74% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, PLJJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PLJJF + JNJ for your $10,000?
Plejd AB (publ), a technology company, develops products and services for smart lighting control in Sweden. The company's product includes universal dimmers for LED and incandescent lights; 2-channel universal dimmer with output for two different loads; dimmer 1-10 V for relay breaking or for controlling third-party products; LED driver with built-in dimming function for one or more LED luminaires; 2-channel relay with two relays to break two separate loads; Relay 16A, a relay with 1 or 2-pole breaking; DALI Broadcast for controlling lighting products through a DALI bus with broadcast functionality; universal dimmer for LED for 1 or 2-pole breaking; gateway that enables remote control and integrations; wireless push and rotary buttons; rotary adapters; battery backup for the clock; and mounting clips and boxes. The company was incorporated in 2009 and is based in Mölndal, Sweden.
Full PLJJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.